These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 21988614)

  • 21. Safety, simplicity and convenience of a modified prefilled insulin pen.
    Sommavilla B; Jørgensen C; Jensen Kh
    Expert Opin Pharmacother; 2008 Sep; 9(13):2223-32. PubMed ID: 18710348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized, cross-over comparison of preference between two reusable insulin pen devices in pen-naïve adults with diabetes.
    Wong M; Abdulnabi R; Carey MA; Fu H
    Curr Med Res Opin; 2013 May; 29(5):465-73. PubMed ID: 23438454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy, safety and acceptability of the new pen needle 33G × 4 mm. AGO 01 study.
    Valentini M; Scardapane M; Bondanini F; Bossi A; Colatrella A; Girelli A; Ciucci A; Leotta S; Minotti E; Pasotti F; Pesenti A; Rocca L; Sciangula L; Vavassori E; Nicolucci A
    Curr Med Res Opin; 2015 Mar; 31(3):487-92. PubMed ID: 25469829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical effectiveness of biphasic insulin aspart 30:70 versus biphasic human insulin 30 in UK general clinical practice: a retrospective database study.
    Morgan CL; Evans M; Toft AD; Jenkins-Jones S; Poole CD; Currie CJ
    Clin Ther; 2011 Jan; 33(1):27-35. PubMed ID: 21397771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin pen needles: effects of extra-thin wall needle technology on preference, confidence, and other patient ratings.
    Aronson R; Gibney MA; Oza K; Bérubé J; Kassler-Taub K; Hirsch L
    Clin Ther; 2013 Jul; 35(7):923-933.e4. PubMed ID: 23790553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative device assessments: Humalog KwikPen compared with vial and syringe and FlexPen.
    Ignaut DA; Schwartz SL; Sarwat S; Murphy HL
    Diabetes Educ; 2009; 35(5):789-98. PubMed ID: 19783767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patient acceptance and reliability of new Humulin/Humalog 3.0 ml prefilled insulin pen in ten Croatian diabetes centres.
    Sucic M; Galic E; Cabrijan T; Ivandic A; Petrusic A; Wyatt J; Mincheva N; Milicevic Z; Malone J
    Med Sci Monit; 2002 Mar; 8(3):PI21-6. PubMed ID: 11884952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: a multinational, randomized, open-label, two-period, crossover noninferiority trial.
    Barnett AH; Burger J; Johns D; Brodows R; Kendall DM; Roberts A; Trautmann ME
    Clin Ther; 2007 Nov; 29(11):2333-48. PubMed ID: 18158075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Once-daily insulin detemir in a cohort of insulin-naïve patients with type 2 diabetes: a sub-analysis from the PREDICTIVE study.
    Meneghini LF; Dornhorst A; Sreenan S;
    Curr Med Res Opin; 2009 Apr; 25(4):1029-35. PubMed ID: 19281426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of multiple daily injection therapy with Humalog mixtures versus separately injected insulin lispro and NPH insulin in adults with type I diabetes mellitus.
    Roach P; Bai S; Charbonnel B; Consoli A; Taboga C; Tiengo A; Bolli G;
    Clin Ther; 2004 Apr; 26(4):502-10. PubMed ID: 15189747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin detemir is associated with more predictable glycemic control and reduced risk of hypoglycemia than NPH insulin in patients with type 1 diabetes on a basal-bolus regimen with premeal insulin aspart.
    Vague P; Selam JL; Skeie S; De Leeuw I; Elte JW; Haahr H; Kristensen A; Draeger E
    Diabetes Care; 2003 Mar; 26(3):590-6. PubMed ID: 12610006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative glycemic control, safety and patient ratings for a new 4 mm x 32G insulin pen needle in adults with diabetes.
    Hirsch LJ; Gibney MA; Albanese J; Qu S; Kassler-Taub K; Klaff LJ; Bailey TS
    Curr Med Res Opin; 2010 Jun; 26(6):1531-41. PubMed ID: 20429832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of QD insulin detemir or neutral protamine Hagedorn on blood glucose control in patients with type I diabetes mellitus using a basal-bolus regimen.
    Russell-Jones D; Simpson R; Hylleberg B; Draeger E; Bolinder J
    Clin Ther; 2004 May; 26(5):724-36. PubMed ID: 15220016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized trial on the influence of the length of two insulin pen needles on glycemic control and patient preference in obese patients with diabetes.
    Kreugel G; Keers JC; Kerstens MN; Wolffenbuttel BH
    Diabetes Technol Ther; 2011 Jul; 13(7):737-41. PubMed ID: 21476936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of usability and patient preference for the new disposable insulin device Solostar versus Flexpen, lilly disposable pen, and a prototype pen: an open-label study.
    Haak T; Edelman S; Walter C; Lecointre B; Spollett G
    Clin Ther; 2007 Apr; 29(4):650-60. PubMed ID: 17617288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deleterious outcomes after abrupt transition from insulin glargine to insulin detemir in patients with type 1 diabetes mellitus.
    Kabadi UM
    Clin Drug Investig; 2008; 28(11):697-701. PubMed ID: 18840012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patient and physician satisfaction with the Humulin/Humalog Pen, a new 3.0-mL prefilled pen device for insulin delivery.
    Bohannon NJ; Ohannesian JP; Burdan AL; Holcombe JH; Zagar A
    Clin Ther; 2000 Sep; 22(9):1049-67. PubMed ID: 11048904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: a randomized trial.
    Esposito K; Ciotola M; Maiorino MI; Gualdiero R; Schisano B; Ceriello A; Beneduce F; Feola G; Giugliano D
    Ann Intern Med; 2008 Oct; 149(8):531-9. PubMed ID: 18936501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Healthcare professional and patient perceptions of a new prefilled insulin pen versus vial and syringe.
    Lajara R; Guerrero G; Thurman J
    Expert Opin Drug Deliv; 2012 Oct; 9(10):1181-96. PubMed ID: 22971161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ease of use and preference for a new disposable self-injection pen compared with a reusable pen for administering recombinant human growth hormone: A multicenter, 2-month, single-arm, open-label clinical trial in patient-caregiver dyads.
    Hey-Hadavi J; Pleil A; Deeb LC; Fuqua JS; Silverman LA; Reiner B; Newfield R; Rajicic N; Wajnrajch MP; Cara JF
    Clin Ther; 2010 Nov; 32(12):2036-47. PubMed ID: 21118739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.